Craven House Capital (CRV) AI Stock Analysis

• Market Cap: $482.95K
• Dividend Yield: N/A
• Average Volume (3M): 8.55K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.59
• Revenue Growth: N/A
• EPS Growth: 85.95%
• Country: UK
• Employees: 3
• Sector: Financial
• Sector Strength: 77
• Industry: Asset Management
• EPS (TTM): 0.00
• Shares Outstanding: 3,863,581
• 10 Day Avg. Volume: 5,200
• 30 Day Avg. Volume: 8,550
• PEG Ratio: -0.01
• Price to Book (P/B): 0.35
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -30.65
• Enterprise Value/Market Cap: 18.38
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: -1.65
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 27 Underperform
• Price Target: ―

Craven House Capital’s overall stock score is significantly constrained by its severe financial distress, characterized by persistent losses, negative equity, and cash flow challenges. The technical indicators further suggest weak momentum and potential downward pressure. Valuation metrics, impacted by a negative P/E ratio and lack of dividend yield, offer little support. These combined factors position the stock at the lower end of the scoring range, indicating considerable risk.

Craven House Capital Business Overview & Revenue Model

Company Description

Craven House Capital Plc operates as an investment company. It focuses on investing in or acquiring a portfolio of companies, partnerships, joint ventures, businesses, or other assets participating in the e-commerce sector. The company was formerly known as AIM Investments plc and changed its name to Craven House Capital Plc in August 2011. Craven House Capital Plc was incorporated in 2004 and is based in London, the United Kingdom.

How the Company Makes Money

Craven House Capital generates revenue through strategic investments and acquisitions. The company makes money by acquiring stakes in businesses that have the potential for significant appreciation. By enhancing the operational efficiencies or market positioning of these companies, Craven House Capital aims to increase their value over time. Revenue is realized through the appreciation of its investment holdings and possible dividends or profits from the companies within its portfolio. Additionally, Craven House Capital may engage in the sale of assets or equity stakes when the investments have matured to generate capital gains. Significant partnerships or joint ventures with local and international firms can also contribute to its earnings, although specific partnerships are not disclosed.

Craven House Capital Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
0.00	0.00	0.00	0.00	0.00	1.59M
	Gross Profit
0.00	0.00	0.00	0.00	0.00	1.59M
	EBIT
―	-818.00K	-5.45M	-180.00K	-2.43M	-719.00K
	EBITDA
0.00	0.00	-5.45M	-180.00K	-1.81M	-6.03M
	Net Income Common Stockholders
0.00	-893.00K	-5.51M	-236.00K	-2.43M	-13.19M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
28.00K	2.00K	4.00K	1.00K	5.00K	6.00K
	Total Assets
648.00K	546.00K	1.18M	6.44M	6.44M	8.05M
	Total Debt
0.00	0.00	0.00	0.00	989.00K	0.00
	Net Debt
-28.00K	-2.00K	-4.00K	-1.00K	984.00K	-6.00K
	Total Liabilities
1.93M	1.82M	1.56M	1.31M	1.08M	254.00K
	Stockholders Equity
-1.28M	-1.28M	-384.00K	5.13M	5.37M	7.80M
Cash Flow		Free Cash Flow
0.00	-56.00K	-148.00K	-196.00K	-990.00K	-4.03M
	Operating Cash Flow
0.00	-56.00K	-148.00K	-196.00K	-990.00K	-4.03M
	Investing Cash Flow
28.00	0.00	0.00	0.00	0.00	144.00K
	Financing Cash Flow
0.00	54.00K	151.00K	192.00K	989.00K	3.85M

Craven House Capital Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRV, the sentiment is Negative. The current price of 0.12 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.17, and below the 200-day MA of 0.22, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 0.60 is Positive, neither overbought nor oversold. The STOCH value of 30.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CRV.

Craven House Capital Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$12.93B	9.81	7.84%	78.03%	12.20%	-7.74%
MILA	48 Neutral	£4.55M	―	-10.47%	―	―	31.58%
GUN	47 Neutral	£994.61K	―	-34.06%	―	―	80.00%
CRV	27 Underperform	$482.95K	―		―	―	85.95%
JADE		£443.01K	―	-224.82%	―	―	―
VOX	40 Underperform	£216.00K	―		―	―	―
SIV		£566.33K	―	-151.72%	―	―	―

Craven House Capital Corporate Events

Craven House Capital Reports Interim Financial Results and Strategic Investment Updates

Craven House Capital PLC’s unaudited interim report for the six months ended November 30, 2024, reveals a modest operating profit of $37,000, despite a loss of $2,000 for the period. The company received a significant share distribution from RoseMonkey Ltd, increasing its stake in QuiaPeg Pharma AB to 23.2%. The report highlights the company’s strategic focus on maintaining and managing its investment portfolio, with valuations of certain private investee companies held at zero due to their pre-revenue status. This financial update underscores the company’s cautious approach in navigating its investments, with implications for stakeholders regarding its strategic positioning in the pharmaceutical and eCommerce sectors.

Craven House Capital Announces Change in Major Shareholder Holdings

Craven House Capital PLC, a UK-based investment firm, has announced changes in its voting rights holdings following a recent acquisition or disposal. The notification details that Peter Gyllenhammar AB, a Stockholm-registered entity, has adjusted its stake in Craven House Capital, reducing its voting rights from 3.26% to 2.87%, which now accounts for 111,000 voting rights. This adjustment reflects a shift in shareholder positions that could influence the company’s governance and decision-making processes.